Characterizing Glioblastoma Heterogeneity via Single-Cell Receptor Quantification

Dysregulation of tyrosine kinase receptor (RTK) signaling pathways play important roles in glioblastoma (GBM). However, therapies targeting these signaling pathways have not been successful, partially because of drug resistance. Increasing evidence suggests that tumor heterogeneity, more specificall...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Bioeng Biotechnol
Auteurs principaux: Chen, Si, Le, Thien, Harley, Brendan A. C., Imoukhuede, P. I.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2018
Sujets:
Bioengineering and Biotechnology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6050407/
https://ncbi.nlm.nih.gov/pubmed/30050899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2018.00092
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires